Article
Development of PARP inhibitors in oncology
21 Nov 2008
Abstract excerpt
Poly (ADP-ribose) polymerase (PARP) plays a key role in DNA repair mechanisms by detecting and initiating repair after DNA strand breaks. Inhibition of PARP in DNA repair-defective tumors (like those with BRCA1 or BRCA2 mutations) can lead to gross genomic instability and cell death. Likewise, combining PARP inhibition with cytotoxic agents such as chemotherapy or radiation therapy is synergistic in many...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
